Obstetrics & Gynecology · Virginia Beach, VA
NPI
1285600320
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1744 Sir William Osler Dr
Virginia Beach, VA, 23454
Phone (757) 481-4036
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
23,486 services
Medicare patients, 2024
347
Average age 72
Drug cost, 2024
$49K
494 prescriptions
Company payments, 2025
$459
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Morris M Elstein was code J1071 (injection, testosterone cypionate, 1 mg), 22,382 times for 63 patients. In total Morris M Elstein billed 23,486 services in 39 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 22,382 | 63 | $0.02 | $376 |
| 96372 Injection Administration | Office | 506 | 66 | $9.28 | $4,694 |
| 99214 Office E&M - Established | Office | 199 | 188 | $71.44 | $14K |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 109 | 109 | $37.58 | $4,096 |
| 99459 Office/Outpatient Services | Office | 71 | 67 | $13.83 | $982 |
| 99213 Office E&M - Established | Office | 59 | 48 | $60.90 | $3,593 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 29 | 29 | $42.62 | $1,236 |
| 99212 Office E&M - Established | Office | 28 | 26 | $40.39 | $1,131 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 15 | 14 | $73.46 | $1,102 |
By year: 2022 $46K for 17,668 services; 2023 $45K for 22,209 services; 2024 $46K for 23,486 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 11 | 11 | $3.47 | $38.16 |
Medicare prescription drug claims, 2024
In 2024, the drug Morris M Elstein prescribed most often to Medicare patients was Progesterone (Progesterone, Micronized), with 49 prescriptions and refills. In total Morris M Elstein wrote 494 Medicare prescriptions that cost $49K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Progesterone Progesterone, Micronized | 49 | 121 | 15 | $1,863 |
| Estradiol Generic | 48 | 156 | 27 | $3,991 |
| Estradiol (Twice Weekly) Estradiol | 36 | 85 | Under 11 | $3,720 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 25 | 36 | Under 11 | $579 |
| Norethindrone Acetate Generic | 24 | 72 | Under 11 | $1,143 |
| Valacyclovir Valacyclovir Hcl | 23 | 55 | Under 11 | $936 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 19 | 19 | Under 11 | $242 |
| Myrbetriq Mirabegron | 15 | 31 | Under 11 | $14K |
| Triamcinolone Acetonide Generic | 14 | 14 | Under 11 | $44.63 |
| Trazodone Hcl Generic | 14 | 42 | Under 11 | $204 |
| Prometrium Progesterone, Micronized | 13 | 13 | Under 11 | $6,399 |
| Bupropion Xl Bupropion Hcl | 12 | 36 | Under 11 | $277 |
Brand drugs: 86 claims; generic drugs: 408 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Morris M Elstein $459 ($459 in general payments such as food, travel and fees) from 9 companies. The largest payer was Astellas Pharma US Inc with $158.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 4 | $158 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $77.83 |
| Exact Sciences Corporation EXAS | 3 | $52.87 |
| Lilly USA, LLC LLY | 3 | $45.62 |
| Novo Nordisk Inc NVO | 2 | $35.91 |
| Millicent US Inc | 2 | $34.19 |
| Provepharm Inc. | 1 | $21.85 |
| Organon LLC OGN | 1 | $17.04 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $15.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.